Overview

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This clinical trial is using EF5 to measure the oxygen level in tumor cells of patients undergoing surgery or surgery biopsy for newly diagnosed supratentorial malignant glioma. Diagnostic procedures using the drug EF5 to measure the oxygen level in tumor cells may help in planning cancer treatment

Phase:

N/A

Details

Lead Sponsor:

National Cancer Institute (NCI)

Treatments:

Etanidazole
Imidazole